MAZE
Market closed

Maze Therapeutics, Inc./$MAZE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Maze Therapeutics, Inc.

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Ticker

$MAZE
Trading on

Industry

Pharmaceuticals

Employees

125

MAZE Metrics

BasicAdvanced
$358M
6.54
$1.25
-
-
$358M
$13.24
$6.71
289K
9.755
9.52
11.171
13.523
23.07%
50.47%
6.544
0.117
-0.06
-0.06
0.262
-102.85%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MAZE

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Maze Therapeutics, Inc. stock?

Maze Therapeutics, Inc. (MAZE) has a market cap of $358M as of April 17, 2025.

What is the P/E ratio for Maze Therapeutics, Inc. stock?

The price to earnings (P/E) ratio for Maze Therapeutics, Inc. (MAZE) stock is 6.54 as of April 17, 2025.

Does Maze Therapeutics, Inc. stock pay dividends?

No, Maze Therapeutics, Inc. (MAZE) stock does not pay dividends to its shareholders as of April 17, 2025.

When is the next Maze Therapeutics, Inc. dividend payment date?

Maze Therapeutics, Inc. (MAZE) stock does not pay dividends to its shareholders.

What is the beta indicator for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. (MAZE) does not currently have a Beta indicator.